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Abstract: A non-contact localized spectroscopic imaging platform has been 
developed and optimized to scan 1x1cm2 square regions of surgically 
resected breast tissue specimens with ~150-micron resolution. A color 
corrected, image-space telecentric scanning design maintained a consistent 
sampling geometry and uniform spot size across the entire imaging field. 
Theoretical modeling in ZEMAX allowed estimation of the spot size, which 
is equal at both the center and extreme positions of the field with ~5% 
variation across the designed waveband, indicating excellent color 
correction. The spot sizes at the center and an extreme field position were 
also measured experimentally using the standard knife-edge technique and 
were found to be within ~8% of the theoretical predictions. Highly 
localized sampling offered inherent insensitivity to variations in 
background absorption allowing direct imaging of local scattering 
parameters, which was validated using a matrix of varying concentrations 
of Intralipid and blood in phantoms. Four representative, pathologically 
distinct lumpectomy tissue specimens were imaged, capturing natural 
variations in tissue scattering response within a given pathology. Variations 
as high as 60% were observed in the average reflectance and relative 
scattering power images, which must be taken into account for robust 
classification performance. Despite this variation, the preliminary data 
indicates discernible scatter power contrast between the benign vs 
malignant groups, but reliable discrimination of pathologies within these 
groups would require investigation into additional contrast mechanisms. 
©2013 Optical Society of America 
OCIS codes: (170.3890) Medical optics instrumentation; (170.6510) Spectroscopy, tissue 
diagnostics; (290.5820) Scattering measurements. 
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1. Introduction 
There is a near complete lack of imaging used to visualize tumor involvement at the margins 
during breast conserving surgery, and this is believed to be a major reason for the fact that the 
majority of women are recalled for additional surgeries. Optical techniques based on 
absorption, fluorescence or other in-elastic light scattering rely on bio-chemical contrast 
mechanisms to distinguish tumors from normal tissue, and often require the use of an 
exogenous contrast agent for imaging. Tissue morphology presents a reliable endogenous 
contrast mechanism to distinguish breast pathologies, and offers a ‘label-free’ approach to 
margin assessment if a sensitive imaging technique could be developed to exploit this 
contrast. In optical imaging, spectral, angular and polarization dependence of elastic light 
scattering provide a comprehensive suite of morphology-sensitive signals that could be used 
to image this intrinsic contrast. In this study, a unique localized spectroscopy system was 
developed to provide a platform from which quantitative spectroscopy of surgical tissues 
could be completed in an imaging geometry. 
Conventional full-field imaging via surgical microscopes coupled to CCD cameras are 
routinely used in OR settings, and could be easily adapted to perform spectral imaging of 
resected specimens. However this technology is not able to image morphological contrast at 
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sufficiently high resolutions because of the overwhelming diffuse background arising from 
the sub-surface tissue structures. In addition, wavelength dependent absorption due to tissue 
chromophores such as hemoglobin and lipids create a non-specific contrast that is difficult to 
decouple from the scattering signal. 
Localized spectroscopy allows high-resolution sampling of the scatter contrast by 
effectively suppressing the diffuse background caused by strong multiple scattering in tissue 
[1, 2]. Signal localization in these geometries restrict light transport to approximately a few 
hundred microns in depth, offering inherent insensitivity to changes in background absorption 
allowing direct sampling of the scatter signal that has not passed through much path-length in 
tissue [1]. In practice, this type of localized signal sampling is easily implemented using 
optical fiber based probes. In fact several optical fiber probes have been developed in the past 
to exploit one or more combinations of optical contrast mechanisms, and have shown 
significant potential to reliably delineate malignant from benign tissues [3–6]. However, 
probe-based techniques only offer limited sampling of tissue regions and hence do not 
adequately capture the high natural variability in local tissue scattering properties. In addition, 
co-registration of probe data with standard histopathology is not trivial at resolution scales 
relevant to surgical margin assessment. 
Direct adaptations of probe-based approaches to imaging can involve mechanically 
scanning or positioning the probe head across the tissue surface, which is time consuming and 
does not scale well for efficient wide field imaging of large tissue specimens, that is needed 
for comprehensive margin assessment [7–11]. Similarly, scanning confocal approaches offer 
sufficient signal localization and imaging capabilities in a scalable, non-contact design that 
can help characterize tissue heterogeneity effectively. Particularly, recent developments have 
highlighted the potential of confocal imaging in detecting skin and oral lesions [12, 13]. But 
the conventional microscopic confocal systems [14] are optimized for high resolution, depth-
sectioned imaging over narrow fields of view, which again is not suitable for imaging cancer 
margins across large fields. While mosaic imaging techniques could be used to extend the 
field of view [15, 16], these designs do not maintain a consistent sampling geometry at each 
pixel position, which makes it particularly unsuitable for imaging tissue scatter signals that 
are known to exhibit spatial and angular dependence [17]. 
A quantitative, noncontact scanning spectroscopic imaging system was developed to 
address these issues and allow better characterization of breast tissue specimens for margin 
assessment applications. The system uses a novel telecentric scanning approach to combine 
dark-field and confocal imaging principles to allow direct imaging of the localized scatter 
contrast in bulk tissue specimens. The telecentric architecture ensures consistent sampling 
geometry throughout the entire imaging field and the dark-field configuration rejects the 
specular reflections arising from the tissue interface, which could lead to reduction in the 
scatter contrast. In this work the imaging system was validated for breast tissue specimen 
imaging. 
2. Materials and methods 
2.1 Scanning in situ Spectroscopy (SiS) imaging platform design 
A Scanning in situ Spectroscopy imaging platform was developed to allow localized 
spectroscopic imaging of 1 cm x 1cm large thick tissue specimens. The design employs a 
novel dark-field illumination and localized detection scheme to raster scan tissue surfaces for 
dense spectral sampling at each pixel. A five-element apochromatic, telecentric scan lens was 
custom designed to maintain a consistent sampling geometry and spot size across the entire 
imaging field, and over the designed waveband (400-700 nm). A schematic of the system is 
presented in Fig. 1 and the design details are highlighted in [18] and reproduced here for 
clarity. In the illumination path, broadband light from a supercontinuum light source (SCL, 
Koheras AG, Denmark) is fiber-coupled into a 200μm core diameter multimode optical fiber 
(IF) through a collimation-refocus assembly (FC), and is wound tightly around a vibrating 
assembly (CS) to minimize speckle noise. Compared to the system in [14] that used a 50μm 
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core diameter fiber, coupling the supercontinuum output to a larger 200μm core diameter 
fiber through FC and CS allowed reduction of speckle noise, but also resulted in a slightly 
larger spot size at the sample plane. Light from the distal end of the multimode fiber is 
collimated back using a custom fabricated optical assembly (L1) consisting of an achromatic 
lens bonded to a 45° micro-rod mirror. L1 produces a hollow collimated beam of light with an 
outer diameter of 10 mm and inner diameter of 6 mm, suitable for dark-field illumination, 
which is scanned by a two-axis galvanometric scanning system (GS) positioned at the 
entrance pupil of a custom designed telecentric scan lens (TCL). The telecentric design allows 
normal illumination of the sample at all field positions, ensuring a consistent sampling 
geometry across the entire sample. A manual micrometer-controlled, two-axis linear 
translation stage (SAM), with a removable glass slide assembly, is used to hold each sample. 
It is mounted such that the top surface of the glass slide is located at the best focus plane of 
TCL. 
 
Fig. 1. (a) A schematic of the dark-field Scanning in situ Spectroscopy (SiS) imaging platform 
(b) a photograph of the SiS platform (c) ZEMAX optical layout of the illumination optical path 
(d) ZEMAX optical layout of the detection optical path. 
In the detection path, the reflected (specular) and scattered light from the glass-tissue 
interface is re-collimated by the TCL, de-scanned by the scanning mirrors, and directed back 
towards L1. In an ideal telecentric and dark-field illumination geometry, all light specularly 
reflected into the detection path would pass through L1 without entering the detection arm 
and scattered light would be collected in the hollow region for direction into the detection arm 
by the mirror portion of L1. However, in the presence of aberrations and slight alignment 
inconsistencies, a portion of the reflected light also enters into the detection arm around the 
periphery of the detection aperture and is blocked using an aperture stop (AS). Another 
achromatic lens (L2) is used to focus the light scattered back from the specimen on the face of 
a 50 micron core diameter optical fiber coupled to a thermoelectrically cooled CCD-based 
imaging spectrometer (SPEC). SiS images are generated by raster scanning the illumination 
spot across the specimen and recording the localized spectral remission at each pixel position. 
In this work, the SiS imaging platform was characterized for imaging localized scattering 
properties of lumpectomy surgical specimens. 
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2.2 ZEMAX modeling and analysis 
The entire illumination optics train, including the scan mirrors, was modeled in ZEMAX to 
optimize the design and to evaluate the overall performance of the imaging optics. Figure 1(c) 
shows the ZEMAX layout of the illumination train from the source fiber to the sample plane. 
The telecentric lens TCL used in this design was custom designed in collaboration with 
Special Optics Inc., NJ. An iterative design approach was used to balance the aberrations in 
the entire optical system to achieve a uniform target spot size at all scan field positions and 
across the entire design waveband of 400-700 nm. The dark-field scanning design required 
excellent telecentricity performance over the entire field, which was the other major design 
focus. 
The multi-configuration layout capability of ZEMAX was used to create individual ray 
traces for nine scan field positions, covering the center and the extreme positions of an 1 cm x 
1 cm scan field as shown in Fig. 2(a). Each configuration corresponds to a specific set of 
deflection angles for the scan mirrors, which ‘scanned’ the focused spot at the sample plane to 
one of the nine locations considered. The fiber face was modeled as a 200μm diameter 
circular disc with uniform illumination, which is a more accurate representation of the source 
compared to the earlier approach of using a collection of point sources to model the fiber 
output as outlined in [18]. 
Further analysis of the optical design revealed that the loss of telecentricity at extreme 
field positions was mainly due to the separation of the X and Y scanning mirrors, which can 
cause a scan angle-dependent pupil shift in the transverse plane. The entrance pupil of the 
TCL is often placed midway between the two scan mirrors along the optical axis to minimize 
the effects of this pupil shift. However, in the presence of other aberrations in the optical 
system, this conventional placement does not always guarantee the best performance. This 
effect was analyzed using ZEMAX; the detection train was modeled by folding the optical 
path at the sample plane by placing a virtual mirror and tracing specularly reflected rays back 
through the illumination optics to the detection fiber. The ZEMAX layout for the detection 
path is shown in Fig. 1(d). The conventional placement of the entrance pupil of TCL at the 
midway position between the two scan mirrors was tested using this model and found to 
produce poor telecentricity performance, not optimizing geometric separation of the 
specularly reflected and scattered light in the detection path. However, shifting the location of 
the entrance pupil away from the midway position and towards the second scanning mirror 
resulted in an optimal placement that minimized this coupling in the detection path. This 
optimal location was used as a starting point in the system fabrication/alignment process and 
fine-tuned to balance telecentricity performance across the entire field. 
2.3 Spot size calculations and measurements 
Complete modeling of the optical system in ZEMAX also allowed theoretical calculation of 
the illumination spot size at the center and at eight positions uniformly distributed within the 
1 cm x 1 cm field. Modeling the fiber face as a circular disc enabled the use of extended 
geometric image analysis feature in ZEMAX to calculate the ‘image’ of the source at the 
focal plane of the TCL for each of the nine positions evaluated here. This analysis accounts 
for all aberrations in the optical system and presents a realistic estimate of the focus spot size 
and its variations over the entire field. The analysis was also done at five discrete and 
uniformly spaced wavelengths spanning the 500-700 nm waveband to assess wavelength 
dependence of the spot size. 
The spot sizes at the center of the field and one of the four extreme corners were also 
experimentally measured using the standard knife-edge technique [19]. Full spectral 
measurements were made at each position, which allowed calculation of the spot size at the 
same discrete wavelengths sampled in ZEMAX for comparison. 
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2.4 Signal stability and repeatability measurements 
Each 1cm x 1cm acquisition requires approximately 12 minutes, so random temporal 
variations in the laser source power could affect scan uniformity. The temporal stability of the 
detected signal was analyzed by acquiring spectra from a spectralon reference standard in a 
continuous manner. The source was allowed to stabilize initially for ~30 minutes and two 
sequential data sets were acquired in 15-minute durations to assess source stability within a 
full field scan and across multiple sequential scans. This entire measurement sequence was 
repeated on another day to assess repeatability. 
2.5 Intralipid and blood phantom measurements 
The localized sampling geometry implemented here is inherently insensitivity to changes in 
local absorption, thereby allowing for nearly direct measurement of scatter features. An array 
of tissue simulating phantoms, consisting of serially diluted blood in increasing 
concentrations of Intralipid, were imaged to assess the ability of the system to quantify scatter 
changes despite variations in background absorption. The volume fraction of Intralipid 
scatterers in the array of phantoms varied from 0.5% to 4%. The total hemoglobin 
concentration was serially diluted from 60μM to 3.8μM using heparinized porcine blood for 
all scattering concentrations. The blood hematocrit level was measured to allow calculating 
the actual hemoglobin concentrations. This array of phantoms adequately spans the range of 
scattering and absorption coefficients relevant to breast tissue, where the typical hemoglogin 
concentration ranges from approximately 10 to 40μM [20]. Measurements were made in glass 
bottom, 24-well plates (MatTe Corporation, Ashland, MA). A 5% Intralipid solution was used 
as the reference in all measurements to account for day-to-day variability in source strength 
and each phantom was thoroughly stirred before measurement to avoid settling issues. 
2.6 Lumpectomy specimen imaging 
Four resected breast tissues, each corresponding to a distinct and clinically relevant diagnosis, 
were acquired from breast conserving surgeries. The Dartmouth Institutional Review Board 
(IRB) approved the tissue procurement and imaging protocol. The tissue sections were 
imaged in an inverted geometry, through a glass plate mounted on the sample holder. The 
four corners of the 1 cm x 1 cm imaging field were marked using pins coated with India ink 
and the sample was immediately sent to pathology for routine histology processing; images 
were co-registered with the most superficial histology section using the holes left by the pins 
and the inked markings. The tissue sections were carefully chosen to represent different breast 
pathologies including, normal pathology (NOR), fibrocystic disease (FCD), invasive breast 
carcinoma (INV) and Ductal Carcinoma In Situ (DCIS). The imaging time for each sample 
was ~12 minutes. All specimens were rinsed in Phosphate Buffered Saline to remove free 
blood from the imaging surface and to keep the samples hydrated during imaging. 
2.7 Spectral parameterization 
The measured spectra at each pixel position were background subtracted and normalized 
relative to measurements from a gray Spectralon standard (SRS-05, LabSphere Inc., NH, 
nominal albedo = 0.05). The albedo of this gray spectralon standard is comparable to that of 
the measured surgical breast tissue specimens, allowing same acquisition settings to be used 
for both the sample and reference scans. The normalized spectral reflectance (R) data were 
then fit to the well-known power law type empirical model of reflectance, R(λ) = A(λ)^(-b), 
to extract the relative scatter power (b) and scatter amplitude (A) parameters. Integrated 
reflectance was also estimated in the 610nm-700nm waveband that avoids the major 
hemoglobin absorption peaks [1, 18]. 
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3. Results 
3.1 ZEMAX spot profile calculations and experimental measurements 
Figure 2(a) shows the theoretical polychromatic spot diagram at the imaging plane, at the 
center and eight extreme positions of the 1 cm x 1 cm imaging field. Figures 2(b-c) show line 
plots across the diameter of focus spots at the center and one of the corner positions of the full 
field. The line plots are shown at five discrete wavelengths within the 500-700 nm waveband. 
Figure 2(c-d) shows the experimentally determined spot size profile measured using the 
standard knife-edge technique. Though full spectral measurements of these line profiles were 
obtained, only the data at discrete wavelengths considered in Fig. 2(b-c) are shown here to 
allow direct comparison with the theoretical spot sizes. 
 
Fig. 2. (a) Focus spot profiles at the sample plane shown at 9 different field positions including 
the center and the extreme field positions (co-ordinates shown are in millimeters). The spots 
are shown enlarged to illustrate size uniformity and shape symmetry expected in a telecentric 
design (b-c) the theoretical estimates of spot size at the center (0,0) and an extreme (5,5) field 
positions. (d-e) experimentally measured spot size at the same field positions 
 
3.2 System characterization and phantom measurements 
Figures 3(a) and 3(b) show the average reflectance image and its histogram for a Spectralon 
sample measured over the 1 cm2 field. A small fraction of pixels in the imaging field are 
shown masked due to signal artifacts caused by dust imperfections on the slide that resulted in 
spurious background data and hardware issues resulting in inconsistent data transfer from the 
spectrometer’s CCD buffer. Figure 3(c) shows the relative standard deviation spectra for two 
sequential 15-minute continuous measurements made at a single field position. To assess 
long-term repeatability the same measurements were repeated on a different day and the 
results are shown in Fig. 3(d). 
Figure 3(e) shows the average scattering spectra acquired from all Intralipid-blood 
measurements relative to the 5% Intralipid solution. Figure 3(f) shows a linear relationship 
between reflectance integrated in the 610-700 nm waveband and the Intralipid concentration. 
Figures 3(g-h) show the plots of the relative scatter amplitude (A) and relative scatter power 
(b) as a function of Intralipid concentration, assuming a power-law dependence on scattering. 
The mean and standard deviations of each scattering parameter as a function of hemoglobin 
variation are plotted in Fig. 3(f-h). 
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Fig. 3. (a) Average reflectance image of a spectralon standard (b) histogram of the average 
reflectance image showing no banding effects or patterns. Coefficient of variation is about 0.1 
(c) Relative standard deviation spectra of two sequential, 15-minute, single spot measurement 
sequences. (d) Results from repeating the same set of measurements in (c) on a different day. 
(e) Reflectance spectra from a matrix of intralipid-blood phantoms, each group represents data 
from one particular intralipid concentration. Background hemoglobin concentrations for each 
group varied from 0 to 60 μM. Only the spectral waveband from 610 to 700nm was used to 
extract the scatter parameters. (f-h) Plots of average reflectance, logarithm of relative scatter 
amplitude and relative scatter power respectively, as a function of intralipid concentration. 
Error bars show variations in estimates due to change in background hemoglobin 
concentration. 
3.4 Lumpectomy specimens imaging 
Figure 4(a-d) shows images of the integrated reflectance and the relative scatter power from 
four pathologically distinct breast tissues, imaged within a 1 cm x 1 cm field of view. Each 
row shows a photograph of the tissue, a superficial histology section co-registered with the 
imaged surface and corresponding maps of the relative scatter power and integrated 
reflectance. Box and whisker plots of the scatter parameters are plotted in Fig. 4(e) and 4(f) to 
show the heterogeneity observed within a given tissue type. 
4. Discussion 
A dark-field telecentric scanning spectroscopy platform was characterized for direct imaging 
of local scatter parameters in surgically excised breast tissues. The inverted imaging geometry 
allowed the breast specimens to conform to the surface of the glass plate to provide a flat 
specimen required for confocal sampling. ZEMAX modeling of the entire optical train was 
used to theoretically estimate the illumination spot size, which was ~168μm in the visible 
waveband explored here. The spot size was also verified experimentally using the standard 
knife-edge technique and was found to be ~154μm, matching the theoretical prediction well. 
Both theoretical and experimental spot profiles demonstrated excellent color correction and 
spot size uniformity across the 1cm x 1cm imaging field and within the design waveband, as 
expected in a telecentric design. Though the scan lens used here can support an imaging field 
of up to 2 cm x 2 cm, the effective field size was reduced because the transverse pupil shift 
caused by the spatially separated 2-axis galvanometric scanning system limited telecentricity 
at the extreme field positions. This slight loss of telecentricity resulted in a significant portion 
of specular light coupling into the detection path, thereby preventing accurate measurements 
of scattered light. 
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Fig. 4. Lumpectomy specimen images and scatter parameters trends for (a) normal (NOR); (b) 
fibrocystic disease (FCD); (c) ductal carcinoma in situ (DCIS), and (d) invasive carcinoma 
(INV). The scatter parameters scatter power (b) and integrated reflectance (Iavg) are shown at 
right, with the white light and H&E shown left. The relative reflectance for each is shown in 
(e) and the relative scatter power, b, shown in (f). 
The homogeneity of the imaging field was tested by scanning 1cm x 1cm of a Spectralon 
standard. The integrated reflectance shown in Fig. 3(a) showed no significant gradients or 
patterns indicating the absence of any field dependent aberrations in the optical system. 
Small-scale random variations observed are likely caused by the minute surface profile 
changes, which occur on length scales of 3-265μm [21]. The signal was stable temporally, as 
evaluated over multiple scan periods and on different days, with an average relative standard 
deviation of ~1.5%. 
Measurements from liquid, tissue simulating phantoms, demonstrate insensitivity of the 
measured scattering signal to changes in absorption over the 610 – 700nm waveband; 
indicating that this localized sampling geometry may be used for direct scatter imaging. 
Scatter spectra were analyzed according to an empirical approximation to Mie scattering, 
which assumes a power law dependence on spectral light scattering. It should be noted that 
the spectra measured here are influenced by changes in both the scattering coefficient and the 
phase function. While it is possible to measure these effects independently by acquiring 
reflectance measurements at multiple angles [22, 23], the current design integrates the 
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scattering spectra across the illumination spot and so only the combined information can be 
measured. 
Finally, scattering images from four distinct, and clinically relevant breast tissue types 
indicate significant variations in the scatter features within a given pathology, as high as 60% 
in some cases. This level of variation is consistent with data obtained from the first generation 
scatter spectroscopy system described here [1]. High-resolution sampling here was enabled by 
a dark-field design to allow quantitative characterization of this natural, spatial variation in 
scattering from local tissue morphology, which is not feasible using probe-based sampling 
and traditional imaging approaches. The preliminary results appear to indicate discernible 
contrast between benign (NOR/FCD) and malignant groups (INV/DCIS) despite the high 
natural variation observed within these pathologies. But delineating INV from DCIS would 
likely be challenging because of the subtle contrast in the relative scatter response. Preserving 
the spatial context thorough imaging allows investigating new contrast mechanisms including 
texture and shape features that could be computed on different size scales, which could 
improve delineation of pathologies in these cases where the local scatter response alone may 
not sufficient. More clinical studies are required to test the performance of this imaging 
technique relative to standard histopathology analysis. 
5. Conclusion 
A non-contact localized spectroscopic imaging platform was developed and validated for 
imaging breast lumpectomy tissue specimens. The entire optical system was modeled in 
ZEMAX for optimization and analysis of system performance. Both theoretical and 
experimental analysis of system performance indicated excellent color correction and 
aberrations control in the optical system that yielded uniform illumination spot sizes across 
the imaging field and designed waveband. Measurements from Intralipid-blood phantoms 
demonstrate the ability of the system to directly image local scatter parameters, independent 
of absorption changes in the range typically observed in breast tissue. Preliminary images of 
scattering from lumpectomy tissues showed significant variations in the local scattering 
response within a given pathology; characterization of this variance within tissue-types is 
critical to improving the performance of tissue classification algorithms. Finally, the modular 
nature of this platform facilitates adaptations that support different imaging modalities and 
optimizing imaging parameters like spot size, numerical aperture etc., which could be used to 
optimize contrast sensitivity of the current design and to investigate complementary contrast 
mechanisms in future studies. 
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